126 related articles for article (PubMed ID: 12903732)
21. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts.
Kuroyanagi Y; Yamada N; Yamashita R; Uchinuma E
Artif Organs; 2001 Mar; 25(3):180-6. PubMed ID: 11284884
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid inhibits adhesion of hepatic stellate cells in spite of its stimulation of DNA synthesis.
Cho MK; Lee GH; Park EY; Kim SG
Tissue Cell; 2004 Oct; 36(5):293-305. PubMed ID: 15385147
[TBL] [Abstract][Full Text] [Related]
23. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection.
Moroi Y; Fujita S; Fukagawa S; Mashino T; Goto T; Masuda T; Urabe K; Kubo K; Matsui H; Kagawa S; Kuroyanagi Y; Furue M
Eur J Dermatol; 2004; 14(3):172-6. PubMed ID: 15246944
[TBL] [Abstract][Full Text] [Related]
24. Development of a wound dressing composed of hyaluronic acid sponge containing arginine and epidermal growth factor.
Matsumoto Y; Kuroyanagi Y
J Biomater Sci Polym Ed; 2010; 21(6-7):715-26. PubMed ID: 20482980
[TBL] [Abstract][Full Text] [Related]
25. Collagenous scaffolds supplemented with hyaluronic acid and chondroitin sulfate used for wound fibroblast and embryonic nerve cell culture.
Drobnik J; Pietrucha K; Piera L; Szymański J; Szczepanowska A
Adv Clin Exp Med; 2017; 26(2):223-230. PubMed ID: 28791838
[TBL] [Abstract][Full Text] [Related]
26. Improvement of the maxillary bone growth suppression in the cleft palate operation with cultured dermal substitute: animal experiment and patient reports in preliminary clinical application.
Kurokawa N; Ueda K; Kuroyanagi Y
J Plast Reconstr Aesthet Surg; 2010 Mar; 63(3):456-8. PubMed ID: 19251505
[TBL] [Abstract][Full Text] [Related]
27. [Advances in regenerative medicine for skin].
Kuroyanagi Y
Nihon Ronen Igakkai Zasshi; 2005 Nov; 42(6):609-15. PubMed ID: 16408496
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix.
Yamada N; Uchinuma E; Kuroyanagi Y
Scand J Plast Reconstr Surg Hand Surg; 1999 Jun; 33(2):147-54. PubMed ID: 10450570
[TBL] [Abstract][Full Text] [Related]
29. A cultured skin substitute composed of fibroblasts and keratinocytes with a collagen matrix: preliminary results of clinical trials.
Kuroyanagi Y; Kenmochi M; Ishihara S; Takeda A; Shiraishi A; Ootake N; Uchinuma E; Torikai K; Shioya N
Ann Plast Surg; 1993 Oct; 31(4):340-9; discussion 349-51. PubMed ID: 8239435
[TBL] [Abstract][Full Text] [Related]
30. Development of anti-adhesive spongy sheet composed of hyaluronic acid and collagen containing epidermal growth factor.
Kuroyanagi M; Yamamoto A; Shimizu N; Toi A; Inomata T; Takeda A; Kuroyanagi Y
J Biomater Sci Polym Ed; 2014; 25(12):1253-65. PubMed ID: 24938709
[TBL] [Abstract][Full Text] [Related]
31. Leukemia inhibitory factor-transfected embryonic fibroblasts and vascular endothelial growth factor successfully improve the skin substitute wound healing by increasing angiogenesis and matrix production.
Akita S; Daian T; Ishihara H; Fujii T; Akino K
J Dermatol Sci; 2004 Oct; 36(1):11-23. PubMed ID: 15488701
[TBL] [Abstract][Full Text] [Related]
32. A study on a chitosan-gelatin-hyaluronic acid scaffold as artificial skin in vitro and its tissue engineering applications.
Liu H; Mao J; Yao K; Yang G; Cui L; Cao Y
J Biomater Sci Polym Ed; 2004; 15(1):25-40. PubMed ID: 15027841
[TBL] [Abstract][Full Text] [Related]
33. Application of cultured dermal substitute for amelioration of maxillary bone growth suppression after cleft palate operation in rats.
Kurokawa N; Ueda K; Tsuji M; Kuroyanagi Y
J Artif Organs; 2008; 11(4):216-20. PubMed ID: 19184287
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor in diabetic mice.
Kondo S; Niiyama H; Yu A; Kuroyanagi Y
J Biomater Sci Polym Ed; 2012; 23(13):1729-40. PubMed ID: 21943516
[TBL] [Abstract][Full Text] [Related]
35. Adherence, proliferation and collagen turnover by human fibroblasts seeded into different types of collagen sponges.
Middelkoop E; de Vries HJ; Ruuls L; Everts V; Wildevuur CH; Westerhof W
Cell Tissue Res; 1995 May; 280(2):447-53. PubMed ID: 7781041
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth on a porous collagen sponge containing hyaluronic acid and fibronectin.
Doillon CJ; Silver FH; Berg RA
Biomaterials; 1987 May; 8(3):195-200. PubMed ID: 3607152
[TBL] [Abstract][Full Text] [Related]
37. [Regenerative medicine for skin].
Kuroyanagi Y
Nihon Ronen Igakkai Zasshi; 2006 May; 43(3):326-9. PubMed ID: 16813088
[TBL] [Abstract][Full Text] [Related]
38. Behaviour of fibroblasts and epidermal cells cultivated on analogues of extracellular matrix.
Doillon CJ; Wasserman AJ; Berg RA; Silver FH
Biomaterials; 1988 Jan; 9(1):91-6. PubMed ID: 3349126
[TBL] [Abstract][Full Text] [Related]
39. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute.
Kashiwa N; Ito O; Ueda T; Kubo K; Matsui H; Kuroyanagi Y
Artif Organs; 2004 May; 28(5):444-50. PubMed ID: 15113338
[TBL] [Abstract][Full Text] [Related]
40. Optimum preservation for autologous cultured dermal substitutes.
Hayama Y; Ueda K; Kuroyanagi Y
Ann Plast Surg; 2010 Sep; 65(3):338-43. PubMed ID: 20733371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
